Call for Abstract

International Congress on Neuroimmunology and Therapeutics, will be organized around the theme “Contemporary explorations in Neuroimmunology to treat human diseases”

neuroimmunology 2015 is comprised of 18 tracks and 167 sessions designed to offer comprehensive sessions that address current issues in neuroimmunology 2015.

Submit your abstract to any of the mentioned tracks. All related abstracts are accepted.

Register now for the conference by choosing an appropriate package suitable to you.

  • Track 1-1Stress
  • Track 1-2Premature Aging
  • Track 1-3Relaxation Therapies
  • Track 1-4Stress management strategy
  • Track 1-5Corticotropin-releasing hormone (CRH)
  • Track 1-6Antipsychotic drugs
  • Track 1-7Autoimmune hypersensitivity
  • Track 1-8 Sympathetic nervous system (SNS)
  • Track 1-9 Hypothalamic-pituitary-adrenal axis (HPA axis)
  • Track 1-10Immune-Brain loop
  • Track 1-11Sleep disorders
  • Track 1-12Mood Disorders
  • Track 1-13Tourette Syndrome
  • Track 1-14Psychotherapy
  • Track 2-1Parkinson’s and Alzheimer’s diseases
  • Track 2-2Amyotrophic lateral sclerosis
  • Track 2-3Therapeutic use
  • Track 2-4Cerebral Palsy
  • Track 2-5Alzheimer’s Disease
  • Track 2-6Multiple Sclerosis
  • Track 2-7Parkinson’s Disease
  • Track 3-1Molecular neuropharmacology: Neurochemical interactions and Neurological disorders and Novel drugs
  • Track 3-2Current research in Behavioral neuropharmacology
  • Track 3-3Computed Tomography (CT) scanning
  • Track 3-4Physical therapy
  • Track 3-5Speech therapy
  • Track 3-6Occupational therapy
  • Track 3-7Antipsychotic drugs
  • Track 3-8Neuroimmunologic Response to Surgical Aggression and Anesthesia
  • Track 4-1Neuroimaging techniques
  • Track 4-2Single-Tandem Repeats (STRs)
  • Track 4-3Single-nucleotide polymorphisms
  • Track 4-4Variable expression of drug receptors
  • Track 4-5Genetic polymorphisms
  • Track 4-6Heterogeneity
  • Track 4-7Pharmacogenomics biomarkers in diseases
  • Track 4-8Arterial spin labeling MRI
  • Track 4-9Pathogenesis in cerebrospinal fluid, blood, or saliva
  • Track 4-10Biomarkers and Neuroimaging in Multiple Sclerosis and Neuromyelitis Optica
  • Track 5-1DNA methylation inhibitors
  • Track 5-2HDAC inhibitors
  • Track 5-3RNA-based approaches
  • Track 5-4Immunoglobulin therapy for inflammatory neuropathy
  • Track 5-5Seretonin Inhibitors
  • Track 6-1Developmental and regenerative Neurobiology
  • Track 6-2Pathogenesis of Immune-mediated Neurological Disorders
  • Track 6-3Epigenetics of Neuroimmunology
  • Track 6-4Neuroimmunomodulation
  • Track 6-5Neuroimmunology and Brain Tumor
  • Track 6-6Immune response
  • Track 6-7Immunopathogenesis of progressive multifocal Leukoencephalopathy (PML)
  • Track 6-8Neuroendocrine cell and current reserach
  • Track 6-9Stem cell therapy in acute Ischemic Stroke
  • Track 6-10Atrial Fibrillation
  • Track 6-11Inflammatory diseases and therapeutics
  • Track 6-12Immunopathogenesis of Paraneoplastic Neurologic Syndrome
  • Track 7-1Cytokines
  • Track 7-2Immune cell trafficking
  • Track 7-3CB2 drugs
  • Track 7-4Pathogen infiltration and endogenous disease agents
  • Track 7-5CNS parenchyma
  • Track 7-6Immunosurveillance in the CNS
  • Track 7-7Innate immune response
  • Track 7-8Corticosteroids-Hormonal signaling
  • Track 7-9Opioids-cellular signaling
  • Track 7-10Auto-immune T-cells
  • Track 7-11Hypothalamic-pituitary-adrenal (HPA) axis
  • Track 7-12Neuroimmune cross-talk
  • Track 8-1Neurogenesis
  • Track 8-2Neuro-imaging
  • Track 8-3Post-Synaptic channels
  • Track 8-4Circadian Rhythms and Sleep Research
  • Track 8-5Neurotransmitters, Neuropeptides and Neurohormones
  • Track 8-6Peripheral nerve injury
  • Track 8-7Neuropathic pain
  • Track 8-8Dendritic cells
  • Track 8-9Astrocytes
  • Track 8-10Transverse Myelitis
  • Track 9-1Bacterial Infections
  • Track 9-2Vasculitic Neuropathy
  • Track 9-3Diagonosis of Chronic Immune-Mediated Polyneuropathies
  • Track 9-4Genetic Neuropathies
  • Track 9-5Carpal Tunnel Syndrome
  • Track 9-6Mononeuropathy or Plexopathy
  • Track 9-7Nerve damage
  • Track 9-8Inherited Neurologic disorders
  • Track 9-9Amyloid Neuropathy
  • Track 9-10Guillain-Barre Syndrome
  • Track 9-11Peripheral Neuropathy
  • Track 10-1Epidemiology of Diseases
  • Track 10-2Chronic Fatigue Syndrome
  • Track 10-3CNS Autoimmunity
  • Track 10-4Myasthenia Gravis
  • Track 10-5Chronic Demyelinating Polyneuropathy
  • Track 10-6Transverse Myelitis
  • Track 10-7Leukoencephalopathies
  • Track 10-8Multiple Sclerosis
  • Track 10-9Therapy of Neurological Infectious disease
  • Track 10-10Pathogenesis
  • Track 10-11Fibromyalgia
  • Track 11-1Schizophrenia
  • Track 11-2Microglia are the phagocytes of macrophage lineage
  • Track 11-3Etiology of Schizophrenia
  • Track 11-4Maternal infection and Autism Spectrum Disorders (ASDs)
  • Track 11-5Inflammatory cytokines as a mediator
  • Track 11-6Glucocorticoids as a mediator
  • Track 11-7Macrophage migration in inflamed lesions
  • Track 11-8Psychosis
  • Track 11-9Tourette Syndrome
  • Track 12-1Stroke and ischemia
  • Track 12-2Brain lesions
  • Track 12-3Epilepsy
  • Track 12-4Chronic pain
  • Track 12-5Sleep disorders
  • Track 12-6Movement disorders (Dystonia; tremor)
  • Track 13-1Parkinsons diseases
  • Track 13-2Huntingtons diseases
  • Track 13-3Fronto-temporal lobe dementia (FTLD)
  • Track 13-4Amyotrophic lateral sclerosis (ALS)
  • Track 13-5Prion diseases (Creutzfeld-Jacob)
  • Track 13-6Fragile X syndrome
  • Track 13-7Myotonic dystrophy
  • Track 13-8Spinobulbar Muscle Dystrophy
  • Track 14-1Meningitis
  • Track 14-2Brain Abscess
  • Track 14-3Epilepsy
  • Track 14-4Central Nervous system
  • Track 14-5Multiple sclerosis
  • Track 14-6Neuromyelitis Optica
  • Track 14-7Late-stage Neurological Trypanosomiasis
  • Track 14-8Progressive Multifocal Leukoencephalopathy (PML)
  • Track 14-9De Vivo disease
  • Track 15-1JC (John Cunningham) virus
  • Track 15-2Viral-induced demyelination
  • Track 15-3Retroviruses
  • Track 15-4Paramyxoviruses
  • Track 15-5Rhabdoviruses
  • Track 15-6Epstein-Barr virus (EBV)
  • Track 15-7Varicella-zoster virus (VZV)
  • Track 15-8Human cytomegalovirus (CMV)
  • Track 15-9Herpesviruses
  • Track 15-10HIV-related neurological disease
  • Track 16-1Neuroimmunogenetics of multiple sclerosis
  • Track 16-2Translational digital medicine
  • Track 16-3MRI brain imaging
  • Track 16-4Immunological and Genetic biomarkers
  • Track 16-5SNPs associated with MS
  • Track 17-1Degenerative disorders
  • Track 17-2Alzheimer’s disease
  • Track 17-3Mood disorders
  • Track 17-4Schizophrenia
  • Track 17-5Small fiber neuropathy
  • Track 17-6Plasmapheresis
  • Track 17-7Intravenous immunoglobulin
  • Track 17-8Autonomic neuropathy
  • Track 17-9Chronic Traumatic Encephalopathy
  • Track 18-1Astrocyte activation
  • Track 18-2Microglial activation
  • Track 18-3Inflammatory mediators
  • Track 18-4Neurodegenerative diseases
  • Track 18-5Clinical Applications
  • Track 18-6Inflammatory Neuropathy
  • Track 18-7Advances in Molecular and Cellular Imaging of Inflammation
  • Track 18-8MRI and Nanoparticles
  • Track 18-9Biomarkers
  • Track 18-10Neuropathic pain
  • Track 18-11Neuroprotective anti-inflammatory therapeutics